PL2970463T3 - Sposoby leczenia i/lub ograniczania rozwoju cukrzycy - Google Patents

Sposoby leczenia i/lub ograniczania rozwoju cukrzycy

Info

Publication number
PL2970463T3
PL2970463T3 PL14709335T PL14709335T PL2970463T3 PL 2970463 T3 PL2970463 T3 PL 2970463T3 PL 14709335 T PL14709335 T PL 14709335T PL 14709335 T PL14709335 T PL 14709335T PL 2970463 T3 PL2970463 T3 PL 2970463T3
Authority
PL
Poland
Prior art keywords
diabetes
treating
methods
limiting development
development
Prior art date
Application number
PL14709335T
Other languages
English (en)
Inventor
Per-Olof Berggren
Lisa JUNTTI-BERGGREN
Original Assignee
Biocrine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrine Ab filed Critical Biocrine Ab
Publication of PL2970463T3 publication Critical patent/PL2970463T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
PL14709335T 2013-03-13 2014-03-12 Sposoby leczenia i/lub ograniczania rozwoju cukrzycy PL2970463T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361779508P 2013-03-13 2013-03-13
EP14709335.5A EP2970463B1 (en) 2013-03-13 2014-03-12 Methods for treating and/or limiting development of diabetes
PCT/EP2014/054862 WO2014140113A1 (en) 2013-03-13 2014-03-12 Methods for treating and/or limiting development of diabetes

Publications (1)

Publication Number Publication Date
PL2970463T3 true PL2970463T3 (pl) 2018-04-30

Family

ID=50241460

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14709335T PL2970463T3 (pl) 2013-03-13 2014-03-12 Sposoby leczenia i/lub ograniczania rozwoju cukrzycy

Country Status (8)

Country Link
EP (1) EP2970463B1 (pl)
JP (2) JP6456853B2 (pl)
KR (1) KR20150127717A (pl)
CN (1) CN104968681B (pl)
DK (1) DK2970463T3 (pl)
ES (1) ES2657090T3 (pl)
PL (1) PL2970463T3 (pl)
WO (1) WO2014140113A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201509575D0 (en) * 2015-06-03 2015-07-15 King S College London Diagnostic target
US10111932B2 (en) 2015-08-26 2018-10-30 Syracuse University Coagonists of glucagon-like peptide 1 receptor and neuropeptide Y2 receptor
IL262728B2 (en) 2016-05-06 2023-10-01 Astrazeneca Ab Oligonucleotides conjugated to the GLP-1 receptor ligand complex and their uses
AU2017378431A1 (en) * 2016-12-14 2019-06-20 Ligandal, Inc. Compositions and methods for nucleic acid and/or protein payload delivery
CN117106024B (zh) * 2022-10-21 2024-05-24 南京市妇幼保健院 一种人血清多肽agdmp1及其在改善胰岛素抵抗中的应用
CN117843807B (zh) * 2023-12-08 2024-10-25 深圳市龙华区人民医院 一种tmem27融合蛋白、全人源单链抗体及其筛选方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033597B2 (en) * 2000-10-13 2006-04-25 Université de Lausanne Intracellular delivery of biological effectors
PL1623228T3 (pl) * 2003-04-29 2013-04-30 Biocrine Ab APOCIII i leczenie oraz diagnozowanie cukrzycy
WO2007097751A1 (en) * 2006-02-22 2007-08-30 The Regents Of The University Of Michigan Methods for reducing glucose intolerance by inhibiting chop
US9023820B2 (en) * 2009-01-26 2015-05-05 Protiva Biotherapeutics, Inc. Compositions and methods for silencing apolipoprotein C-III expression
KR20130097789A (ko) * 2010-10-15 2013-09-03 코넬 유니버시티 내분비, 위장관 또는 자가면역 장애 치료를 위한 조성물 및 방법
US8557513B2 (en) * 2011-06-27 2013-10-15 Biocrine Ab Methods for treating and/or limiting development of diabetes

Also Published As

Publication number Publication date
DK2970463T3 (en) 2018-01-22
ES2657090T3 (es) 2018-03-01
HK1212999A1 (en) 2016-06-24
KR20150127717A (ko) 2015-11-17
EP2970463B1 (en) 2017-11-29
CN104968681A (zh) 2015-10-07
CN104968681B (zh) 2020-03-17
JP7111605B2 (ja) 2022-08-02
WO2014140113A1 (en) 2014-09-18
EP2970463A1 (en) 2016-01-20
JP6456853B2 (ja) 2019-01-23
JP2019065025A (ja) 2019-04-25
JP2016517400A (ja) 2016-06-16

Similar Documents

Publication Publication Date Title
GB2518286B (en) Security device and method of manufacture
GB201320723D0 (en) Composition and methods of treatment
HUE039560T2 (hu) Mikro méretû zárófedés és kapcsolódó eljárások bõr kezelésére
SG11201601412XA (en) Compositions and methods for the treatment of presbyopia
PT2948448T (pt) Análogos de tiadiazol e o seu uso para tratamento de doenças associadas a uma deficiência de neurónios motores smn
GB2513304B (en) Peripheral apparatus and method of construction
IL244268A0 (en) Heterocyclic compounds and methods of use
PL2970463T3 (pl) Sposoby leczenia i/lub ograniczania rozwoju cukrzycy
PL2936151T3 (pl) Sposoby leczenia i/lub ograniczania rozwoju cukrzycy
PL3074038T3 (pl) Sposób leczenia nefropatii cukrzycowej
PL3074033T3 (pl) Związki do leczenia otyłości i sposoby ich zastosowania
PL3065751T3 (pl) Sposób leczenia raka i chorób współistniejących
IL241096A0 (en) Treatment methods
GB201311984D0 (en) Methods and compounds for preventing or treating osteoarthritis
LT2992094T (lt) I tipo diabeto gydymo būdai ir kompozicijos
ZA201601626B (en) Treatment of gases
HRP20181181T1 (hr) Postupak obrade i liječenja lišmenioze uporabom feksinidazola
IL245675A0 (en) Therapeutic regimen and method for treating type 2 diabetes
GB201322778D0 (en) Method of treatment
GB201314882D0 (en) Method of treatment
GB201321848D0 (en) Lock means and method of use thereof
ZA201302565B (en) Methods for treating hyperuricemia and related diseases
GB201302105D0 (en) Cover Means and Method of Use Thereof
AU2013904467A0 (en) Regimen and method for treatment of type 2 diabetes